Conquer Cancer®, the ASCO Foundation, Grants & Awards Program offers a comprehensive portfolio of funding opportunities for every career stage, supporting the brightest minds in cancer research in every area of oncology.​Applicants are highly encouraged to visit the Application Resources page to utilize ASCO’s grant writing resources, view application FAQ’s and sample applications, and sign-up for one-on-one virtual office hours with Conquer Cancer staff.
Trainees and/or Early Career Opportunities
YIA Special Competitions
YIA Special Competitions are open for specific topics noted below:
- Chronic Lymphocytic Leukemia
- Drug Development
- Geriatric Oncology
- Invasive Lobular Breast Cancer
- Mantel Cell Lymphoma
- Primary Brain Tumors
- Supportive Care
- Survivorship Research
- Veteran Cancer
Deadlines Vary: View more information.
Career Development Award (CDA) in Triple Negative Breast Cancer
The CDA provides funding to clinical investigators who have received their initial faculty appointment and are establishing an independent research career in clinical oncology focused on Triple Negative Breast Cancer. This is a mentored award, and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Open to U.S. applicants only.
Applications Due:Â March 12, 2026, by 11:59 PM (ET)
Low- and Middle-Income Countries (LMICs)
Long-term International Fellowship (LIFe)
The LIFe program provides early-career oncologists in LMICs with six months of mentor-led training at a host institution in the U.S., Canada, or Europe, followed by six months or up to 12 months of virtual mentorship to improve cancer care in their home country.
Applications Due:Â January 29, 2026, by 11:59 PM (ET)
Mid- Career
Deadline Extended! Women Who Conquer Cancer Mentorship Awards
This award honors leaders who have demonstrated outstanding commitment to the professional development of their colleagues as clinicians, educators, and researchers. Nominate a woman who inspires you!
Nominations Due: January 9, 2026, by 11:59 PM (ET).
